Le Lézard
Classified in: Health
Subjects: NPT, SVY

Neurologists Describe Childhood Absence Epilepsy as 'Underrecognized' but 'Easily Diagnosed and Treated'


Expanding awareness of Childhood Absence Epilepsy helps early diagnosis and treatment

WASHINGTON, May 6, 2024 /PRNewswire/ -- The subtlety of childhood absence epilepsy (CAE) seizures, coupled with their close association with learning and mental health difficulties, can delay diagnosis despite CAE being one of the most common pediatric syndromes in the United States, according to a new expert-led clinical proceedings paper from the Clinical Neurological Society of America.

Childhood absence epilepsy seizures are brief staring spells with loss of awareness that cannot be interrupted by voice or touch. Seizures can occur multiple times per day. CAE may go undiagnosed or misdiagnosed because it can be mistaken for ADHD or be difficult for parents, teachers and other caregivers to recognize. While CAE usually remits within two years of onset or by early adolescence, the impact on children's social and emotional health can be long term. 

The paper, Childhood Absence Epilepsy: An Underrecognized Condition, Yet Easily Diagnosed and Treated, is authored by four pediatric neurologists and calls for:

Expert Panelists:

Statement from Katy Lalor, MD, Clinical Proceedings Chair:

"Expanding awareness among the public of CAE is the first step to earlier diagnosis and treatment. And with a greater understanding of CAE's link to ADHD and other learning and mental health challenges, we can reduce the burden of this disease and improve the short-term and long-term outcomes of these children."

Learn more by reading "Childhood Absence Epilepsy: An Underrecognized Condition, Yet Easily Diagnosed and Treated."

The Clinical Neurological Society of America, a non-profit 501(c)(6), is a nationwide organization of neurology clinicians with a mission to improve clinical practice and patient care through education. 

SOURCE Clinical Neurological Society of America


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: